ArticleAmerican journal of cancer research2022

Recombinant human endostatin injection (Endostar) combined with PF chemotherapy and sequential intensity-modulated radiotherapy is tolerable and improves prognosis of locally advanced nasopharyngeal carcinoma: a randomized, open, multicenter phase II clinical study.

Lu Xu et al.PubMed ↗Full text ↗

No numbers read from the abstract.